Assessing the effect of COVID-19 pandemic on air quality change and human health outcomes in a capital city, southwestern Iran.

The aimsof this study were to assess the spatial variation of PM2.5, NO2, and O3 between 2019 (before) and 2020 (during COVID-19 pandemic); and calculation the health outcomes of exposure to these pollutants. The daily PM2.5, NO2, and O3 concentrations were applied to assess health effects by relative risk, and baseline incidence. The annual PM2.5 and NO2 mean concentrations exceeded the WHO guideline values, while O3 did not exceed. The restrictive measures associated to COVID-19 led to reduction at the annual means of PM2.5 and NO2 by -25.5% and -23.1%, respectively, while the annual mean of O3 increased by +7.9%. The number of M-CVD and M-RD (-25.6%, -26.1%) related to PM2.5 exposure, and HA-COPD and HA-RD >65 years old (-21% and -3.84%) related to NO2 exposure were reduced in 2020, and O3 exposure-related M-CVD (+30.1%) and HA-RD >65 years old (+23.4%) increased compared to the previous year 2019.

Ambient PM2.5 and O3 pollution and health impacts in Iranian megacity.

The main objectives of this study were to (i) assess variation within fine particles (PM2.5) and tropospheric ozone (O3) time series in Khorramabad (Iran) between 2019 (before) and 2020 (during COVID-19 pandemic); (ii) assess relationship between PM2.5 and O3, the PM2.5/O3 ratio, and energy consumption; and (iii) estimate the health effects of exposure to ambient PM2.5 and O3. From hourly PM2.5 and O3 concentrations, we applied both linear-log and integrated exposure-response functions, city-specific relative risk, and baseline incidence values to estimate the health effects over time. A significant correlation was found between PM2.5 and O3 (r =-0.46 in 2019, r =-0.55 in 2020, p < 0.05). The number of premature deaths for all non-accidental causes (27.5 and 24.6), ischemic heart disease (7.3 and 6.3), chronic obstructive pulmonary disease (17 and 19.2), and lung cancer (9.2 and 6.25) attributed to ambient PM2.5 exposure and for respiratory diseases (4.7 and 5.4) for exposure to O3 above 10 µg m-3 for people older than 30-year-old were obtained in 2019 and 2020. The number of years of life lost declined by 11.6% in 2020 and exposure to PM2.5 reduced the life expectancy by 0.58 and 0.45 years, respectively in 2019 and 2020. Compared to 2019, the restrictive measures associated to COVID-19 pandemic led to reduction in PM2.5 (-25.5%) and an increase of O3 concentration (+ 8.0%) in Khorramabad.

Increased tropospheric ozone levels as a public health issue during COVID-19 lockdown and estimation the related pulmonary diseases.

The aims of this study were to i) investigate the variation of tropospheric ozone (O3) levels during the COVID-19 lockdown; ii) determine the relationships between O3 concentrations with the number of COVID-19 cases; and iii) estimate the O3-related health effects in Southwestern Iran (Khorramabad) over the time period 2019-2021. The hourly O3 data were collected from ground monitoring stations, as well as retrieved from Sentinel-5 satellite data for showing the changes in O3 levels pre, during, and after lockdown period. The concentration-response function model was applied using relative risk (RR) values and baseline incidence (BI) to assess the O3-related health effects. Compared to 2019, the annual O3 mean concentrations increased by 12.2% in 2020 and declined by 3.9% in 2021. The spatiotemporal changes showed a significant O3 increase during COVID-19 lockdown, and a negative correlation between O3 levels and the number of COVID-19 cases was found (r = - 0.59, p < 0.05). In 2020, the number of hospital admissions for cardiovascular diseases increased by 4.0 per 105 cases, the mortality for respiratory diseases increased by 0.7 per 105 cases, and the long-term mortality for respiratory diseases increased by 0.9 per 105 cases. Policy decisions are now required to reduce the surface O3 concentrations and O3-related health effects in Iran.

Chronic obstructive pulmonary diseases related to outdoor PM10, O3, SO2, and NO2 in a heavily polluted megacity of Iran.

This study was conducted to quantify, by an approach proposed by the World Health Organization (WHO), the daily hospital admissions for chronic obstructive pulmonary disease (COPD) related to exposure to particulate matter (PM10) and oxidants such as ozone (O3), sulfur dioxide (SO2), and nitrogen dioxide (NO2) in a heavily polluted city in Iran. For the health impact assessment, in terms of COPD, the current published relative risk (RR) and baseline incidence (BI) values, suggested by the WHO, and the 1-h O3 concentrations and daily PM10, NO2, and SO2 concentrations were compiled. The results showed that 5.9, 4.1, 1.2, and 1.9% of the COPD daily hospitalizations in 2011 and 6.6, 1.9, 2.3, and 2.1% in 2012 were attributed to PM10, O3, SO2, and NO2 concentrations exceeding 10 µg/m3, respectively. This study indicates that air quality and the high air pollutant levels have an effect on COPD morbidity. Air pollution is associated with visits to emergency services and hospital admissions. A lower relative risk can be achieved if some stringent control strategies for reducing air pollutants or emission precursors are implemented.